No Data
Earnings Preview: ANIP to Report Financial Results Pre-market on November 08
ANI Pharmaceuticals to Present at Guggenheim's Inaugural Healthcare Innovation Conference and Jefferies London Healthcare Conference in November
ANI Pharmaceuticals to Discuss Third Quarter 2024 Financial Results on November 8, 2024, at 8:00 A.m. ET
Truist Financial Keeps Their Hold Rating on ANI Pharmaceuticals (ANIP)
ANI Pharmaceuticals Launches Estradiol Gel After Final FDA Approval
ANI Pharmaceuticals ANIP FDA Approval; IDEAYA IDYA Phase 1 Data
ANI Pharmaceuticals (NASDAQ:ANIP) Delivers Shareholders Respectable 19% CAGR Over 3 Years, Surging 5.9% in the Last Week Alone
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}